Weil Company Inc. increased its stake in shares of Singular Genomics Systems, Inc. (NASDAQ:OMIC – Free Report) by 73.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 118,202 shares of the company’s stock after buying an additional 50,000 shares during the […]
Singular Genomics Systems, Inc. (NASDAQ:OMIC – Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 911,200 shares, a drop of 17.2% from the December 31st total of 1,100,000 shares. Currently, 2.2% of the company’s shares are short sold. Based on […]
Singular Genomics Systems (NASDAQ:OMIC – Free Report) had its price objective cut by The Goldman Sachs Group from $0.95 to $0.85 in a research note published on Monday, Benzinga reports. They currently have a neutral rating on the stock. Singular Genomics Systems Stock Performance OMIC opened at $0.43 on Monday. The stock has a market […]
Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) had its price target dropped by equities research analysts at The Goldman Sachs Group from $0.95 to $0.85 in a note issued to investors on Monday, Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential […]
Singular Genomics Systems (NASDAQ:OMIC – Free Report) had its price target lowered by The Goldman Sachs Group from $0.95 to $0.85 in a research report report published on Monday, Benzinga reports. The firm currently has a neutral rating on the stock. Singular Genomics Systems Price Performance Shares of OMIC opened at $0.42 on Monday. The […]